TITXF News Alert Titan Medical Inc (TITXF) 1.3300 12/06/2014

New Post Public Reply Private Reply Replies (0) Message Board

Dec 6, 2014 at 11:54 PM

Titan Medical Inc (TITXF) 1.3300 $TITXF

Market Maker Surveillance Report. SSI, DL, EBR, TITXF, BODY, AGIO, Winning Stocks With Lowest Price Friction For Wednesday, November 19th 2014
M2 - Thu Nov 20, 3:42AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4516 companies with "abnormal" market making, 1857 companies with positive Friction Factors and 3256 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. STAGE STORES, INC. (NYSE:SSI), Danier Leather Inc (NYSE

L), Centrais Eletricas Brasileiras SA (NYSE:EBR), TITAN MEDICAL INC (OTC:TITXF), Body Central Corp (OTC:BODY), (NASDAQ:AGIO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
DL: 17.94 (+0.10), SSI: 19.60 (+0.08), EBR: 2.19 (-0.11), AGIO: 106.02 (+1.97)

OTC Daily Alert Stock Watch - Titan Medical Inc. (TSX VENTURE:TMD) (OTCQX:TITXF)
WorldStockWire - Fri Nov 14, 11:30AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
TMD.VN: 2.440 (+0.070)

Titan Medical Inc. Announces Results for the Three and Nine Months Ended September 30, 2014
Marketwired - Fri Nov 14, 6:01AM CST
Titan Medical Inc. ("Titan" or the "Company"

(TSX: TMD) (OTCQX: TITXF) today announced financial results for the three and nine months ended September 30, 2014. All financial results are reported in U.S. dollars, unless otherwise stated.
TMD.TO: 1.49 (+0.04)

Titan Medical Inc. Announces Receipt of Final Approval to Graduate to TSX
Marketwire - Mon Sep 29, 6:01AM CDT
Titan Medical Inc. ("Titan" or the "Company"

(TSX VENTURE: TMD) (OTCQX: TITXF) today announced that, effective at market opening on September 30, 2014, Titan's common shares and warrants will commence trading on the Toronto Stock Exchange ("TSX"

. Concurrent with the TSX listing, the Company's common shares and warrants will be de-listed from the TSX Venture Exchange.
TMD.VN: 2.440 (+0.070)

Titan Medical Inc. Announces the Formation of Its Surgeon Advisory Board
Marketwire - Thu Sep 25, 6:01AM CDT
Titan Medical Inc. ("Titan" or the "Company"

(TSX VENTURE: TMD)(OTCQX: TITXF) today announced that it has formed a Surgeon Advisory Board (SAB) that includes seven industry-renowned surgeons who specialize in minimally invasive procedures.
TMD.VN: 2.440 (+0.070)

Titan Medical Inc. Appoints Dr. Dennis Fowler as Executive Vice President, Clinical and Regulatory Affairs
Marketwire - Tue Sep 09, 6:03AM CDT
Titan Medical Inc. ("Titan" or the "Company"

(TSX VENTURE: TMD)(OTCQX: TITXF) today announced that Dr. Dennis Fowler, who currently serves as the Company's Director of Clinical Affairs, has been appointed to the newly-created position of Executive Vice President, Clinical and Regulatory Affairs.
TMD.VN: 2.440 (+0.070)

Titan Medical Inc. Announces DTC Eligibility
Marketwire - Wed Sep 03, 6:01AM CDT
Titan Medical Inc. ("Titan" or the "Company"

(TSX VENTURE: TMD)(OTCQX: TITXF) announced today that the Depository Trust Company (DTC) has approved the Company's eligibility application for Titan Medical Inc. (CUSIP 88830X108), effective August 21, 2014.
TMD.VN: 2.440 (+0.070)

Titan Medical Inc. Announces Results for the Three and Six Months Ended June 30, 2014
Marketwire - Wed Aug 13, 8:46AM CDT
Titan Medical Inc. ("Titan" or the "Company"

(TSX VENTURE: TMD)(OTCQX: TITXF) announced today financial results for the three and six months ended June 30, 2014. All financial results are reported in U.S. dollars, unless otherwise stated.
TMD.VN: 2.440 (+0.070)

With Only One Product to Hope For, the Source of Downside Risks Are Numerous and Diverse; Analyst Report by BrokerBank Securities, Inc.
PR Newswire - Mon Jun 30, 1:30PM CDT
Titan Medical Inc. (OTCQX: TITXF) is a venture company with a market capitalization of about $200 million. Headquartered in Toronto, Canada. The company is involved in building a robotic surgical tool for application in minimally invasive surgery ("MIS"

. The key concept of MIS is to minimize the incision area during the surgical operation. In general, MIS leads to quicker recovery, shorter hospital stays, less pain, fewer and smaller scars, reduced risk of infection, and less blood loss.

Titan Medical Inc. Corporate Update
Marketwire Canada - Mon Jun 30, 6:00AM CDT
Titan Medical Inc. (the "Company"

(TSX VENTURE:TMD) (OTCQX:TITXF) announced today that Mr. Joe Talarico, Senior Vice President Business Development has resigned his position with the Company. We would like to thank Joe for his contribution to Titan during his four years with the Company. In the interim John Hargrove, Chairman and CEO will assume the responsibilities for Business Development.
TMD.VN: 2.440 (+0.070)

Titan Medical Inc. Retains New York-Based Bertner Advisors, LLC for Investor Relations Services
Marketwire - Wed Jun 18, 1:29AM CDT
Titan Medical Inc. ("Titan" or the "Company"

(TSX VENTURE: TMD)(OTCQX: TITXF) announced today that it has retained Bertner Advisors, LLC as its investor relations advisor. Services to be provided in the United States to Titan by Bertner Advisors include counsel on investor relations strategy.
TMD.VN: 2.440 (+0.070)

Titan Medical Inc. Announces Completion of Key Milestone in the Development of Its SPORT(TM) Surgical System
Marketwire - Mon Jun 16, 6:01AM CDT
Titan Medical Inc. (the "Company"

(TSX VENTURE: TMD)(OTCQX: TITXF) announced today that it successfully completed animal tissue studies on May 30, 2014, performing a full cholecystectomy (gallbladder removal) procedure using the SPORT Surgical System alpha commercial prototype for the required surgical tasks (including grasping, dissecting, mono-polar cautery and suturing). This comes after the recent successful completion of the Q1 2014 milestone of completing an alpha commercial prototype. "We are most pleased to confirm this key milestone of the successful completion of an actual non-human surgical procedure. The procedure was extensively validated by reviewing video footage of the surgical field and instruments from several viewing angles," said John Hargrove, Titan Medical Chairman and CEO. He further stated, "This is what we expected and targeted for our goals-we have a great team, a great technology and a tremendous opportunity. The development of the SPORT Surgical System remains on schedule."
TMD.VN: 2.440 (+0.070)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FutureVault's AI Agents: Transforming Financial Workflows

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Succession Planning in Turmoil: Only 42% Ready

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Davos Healthcare Aims to Revolutionize Hospital Ratings

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Machine Grabs Prime Dallas Property Amid Apartment Boom

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...